Relationship between antimycobacterial activities of rifampicin, rifabutin and KRM-1648 and rpoB mutations of Mycobacterium tuberculosis.
about
Molecular characterization of rpoB mutations conferring cross-resistance to rifamycins on methicillin-resistant Staphylococcus aureusX-ray Crystal Structures of the Escherichia coli RNA Polymerase in Complex with BenzoxazinorifamycinsThe molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosisCorrelation between genotypic and phenotypic testing for resistance to rifampin in Mycobacterium tuberculosis clinical isolates in Haiti: investigation of cases with discrepant susceptibility resultsQuantitative drug-susceptibility in patients treated for multidrug-resistant tuberculosis in Bangladesh: implications for regimen choice.Genetic evaluation of relationship between mutations in rpoB and resistance of Mycobacterium tuberculosis to rifampin.Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technologyComparison of Xpert MTB/RIF with line probe assay for detection of rifampin-monoresistant Mycobacterium tuberculosis.Isothermal RNA sequence amplification method for rapid antituberculosis drug susceptibility testing of Mycobacterium tuberculosis.Frequency of rpoB mutations inside and outside the cluster I region in rifampin-resistant clinical Mycobacterium tuberculosis isolates.In vitro activity of novel rifamycins against rifamycin-resistant Staphylococcus aureusExploiting current understanding of antibiotic action for discovery of new drugs.Rapid detection of rifampin resistance in Mycobacterium tuberculosis by Pyrosequencing technologyRapid detection of rifampin resistance in Mycobacterium tuberculosis isolates by heteroduplex analysis and determination of rifamycin cross-resistance in rifampin-resistant isolates.Use of DNA extracts from Ziehl-Neelsen-stained slides for molecular detection of rifampin resistance and spoligotyping of Mycobacterium tuberculosisMutation analysis of mycobacterial rpoB genes and rifampin resistance using recombinant Mycobacterium smegmatis.Direct detection of multidrug-resistant Mycobacterium tuberculosis in clinical specimens in low- and high-incidence countries by line probe assay.Comparison of Three Commercial Molecular Assays for Detection of Rifampin and Isoniazid Resistance among Mycobacterium tuberculosis Isolates in a High-HIV-Prevalence SettingRifampicin resistance in tuberculosis outbreak, London, England.Rifampicin resistance mutations in the 81 bp RRDR of rpoB gene in Mycobacterium tuberculosis clinical isolates using Xpert MTB/RIF in Khyber Pakhtunkhwa, Pakistan: a retrospective study.Rapid detection of rpoB gene mutations conferring rifampin resistance in Mycobacterium tuberculosis.Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.Predicting differential rifamycin resistance in clinical Mycobacterium tuberculosis isolates by specific rpoB mutations.Rifabutin and rifampin resistance levels and associated rpoB mutations in clinical isolates of Mycobacterium tuberculosis complex.Rifampicin reduces susceptibility to ofloxacin in rifampicin-resistant Mycobacterium tuberculosis through effluxRifampin drug resistance tests for tuberculosis: challenging the gold standard.Whole-cell screening-based identification of inhibitors against the intraphagosomal survival of Mycobacterium tuberculosis.Direct detection of rifampin-resistant mycobacterium tuberculosis in respiratory specimens by PCR-DNA sequencing.Rifampin-resistant RNA polymerase mutants of Chlamydia trachomatis remain susceptible to the ansamycin rifalazilEmergence of resistance to rifampin and rifalazil in Chlamydophila pneumoniae and Chlamydia trachomatis.Medical treatment of pulmonary multidrug-resistant tuberculosis.Resistance to rifampicin: a review.The future for early-stage tuberculosis drug discoveryDrug Resistance Mechanisms in Mycobacterium tuberculosis.Revisiting susceptibility testing in MDR-TB by a standardized quantitative phenotypic assessment in a European multicentre study.Efficacy of novel rifamycin derivatives against rifamycin-sensitive and -resistant Staphylococcus aureus isolates in murine models of infectionMutations in the beginning of the rpoB gene can induce resistance to rifamycins in both Helicobacter pylori and Mycobacterium tuberculosis.The spectrum of spontaneous rifampin resistance mutations in the rpoB gene of Bacillus subtilis 168 spores differs from that of vegetative cells and resembles that of Mycobacterium tuberculosis.Profiling of rpoB mutations and MICs for rifampin and rifabutin in Mycobacterium tuberculosis.Effect of rpoB mutations conferring rifampin resistance on fitness of Mycobacterium tuberculosis.
P2860
Q24550636-376FF713-FA51-4C50-BA02-3EB40BD5C5B9Q27678165-F9689D7D-F145-4D12-BA22-FF321A124692Q28362898-5CADD0DE-2871-4103-9736-101C90CB9410Q28540488-09134561-9C07-4297-B863-2CD9DB59B17DQ28543642-DE513116-A779-4465-B830-684C0C8B07C9Q30857084-097E2048-5191-479A-A5E3-EB4BA7F4FD20Q33614228-7BDC4005-0337-4957-B701-B21E0A1CAB48Q33703611-C3125E05-3C0B-4B38-83F9-DAB5F1246C62Q33859255-BED29EFD-9A7D-49E1-92E8-8192DC6A8C76Q33970864-76AC5EED-9583-4374-9470-E332869E916DQ34509698-F416765E-8E87-4FEC-B486-72D35C1302FFQ34631418-3C767F09-7C59-441B-A15F-FE3B31CC249CQ34719421-78CE481E-B11D-46E3-993A-3106F77D112BQ34751498-EA2872BA-8716-4711-8B4D-27A3960532C4Q34774128-0D996761-AEED-44EC-8E51-F05382487538Q35867423-980B4997-46C9-4591-9F08-EC2CDA590DE1Q35922907-A5FEA214-1E04-43CD-882F-449953AE5A3EQ35968590-DF33F3F4-D947-4A18-A575-F30BDE6C6E30Q36009343-1A4887F8-84BC-47F4-9510-EDC9EF64081AQ36103146-EC8B95E0-8BF8-4ACF-B01B-4A7ABA33F368Q36118584-7EFF5810-3ADB-4B74-B660-885FB5EC0D62Q36156072-22660FFA-7EE7-48A3-9ECA-22C80E31ED95Q36169719-2B924F15-F0DD-4E3C-AEE5-3448F3BC1DEEQ36917933-67BC47B2-0B83-4117-A70E-9614A47D522CQ36974201-72C09265-2C9B-4480-8945-49FA1FDFC63FQ37036190-789CCDAB-1411-4177-BFC8-D96ED303A89EQ37335738-03896737-BFAF-41C4-BCCE-F7D995AD263FQ37576334-EA29063F-D48E-4C63-ADA0-E7F567C57930Q37865419-B5BF730F-7A0A-4F9A-B8A9-C362760E84A9Q37865423-6E26A2C0-756B-4F57-A30D-18ED1BAE581CQ38182982-7701ACA5-E76E-40EC-A4CF-17B2D437E9D1Q38239459-A7C020C9-9C77-4AE8-A2DF-4CD1DCB548A8Q38358621-B22D374C-970F-408B-BC7F-BE7B37F78893Q38792870-19EB0EC0-7BDC-4EE5-9ADE-3EA6CA587A87Q38929849-8C324A73-30D3-4215-96A4-B700540A0C29Q39078400-286B54E4-4EB2-46C3-82A3-A8F72BEF26F6Q39473557-5A2D3862-CAEC-4D55-8D94-3CECD62DB7A0Q39680067-69EDD3C9-6EFE-44C1-8595-50DA1CADF69BQ40209976-CBADD2B4-FE8D-4F0C-A8D0-217EB5CA49DDQ40572948-AD394571-9004-4EDF-A4A5-1BD349D4971A
P2860
Relationship between antimycobacterial activities of rifampicin, rifabutin and KRM-1648 and rpoB mutations of Mycobacterium tuberculosis.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Relationship between antimycob ...... of Mycobacterium tuberculosis.
@en
Relationship between antimycob ...... of Mycobacterium tuberculosis.
@nl
type
label
Relationship between antimycob ...... of Mycobacterium tuberculosis.
@en
Relationship between antimycob ...... of Mycobacterium tuberculosis.
@nl
prefLabel
Relationship between antimycob ...... of Mycobacterium tuberculosis.
@en
Relationship between antimycob ...... of Mycobacterium tuberculosis.
@nl
P2093
P356
P1476
Relationship between antimycob ...... of Mycobacterium tuberculosis.
@en
P2093
Hirakata Y
P304
P356
10.1093/JAC/42.5.621
P407
P577
1998-11-01T00:00:00Z